Atlanta Cancer Center

Atlanta, Georgia 30342

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Pancreatic Cancer

Studies at this site

• Study of Ribociclib With Everolimus + Exemestane in HR+ HER2- Locally Advanced/Metastatic Breast Cancer Post Progression on CDK 4/6 Inhibitor. — Completed
• OSI-774 (Tarceva) Plus Gemcitabine in Patients With Locally Advanced, Unresectable or Metastatic Pancreatic Cancer. — Completed